Drug Screening Market is projected to reach USD 10.0 billion by 2025

The global drug screening market is projected to reach USD 10.0 billion by 2025, from USD 4.5 billion in 2020, at a CAGR of 17.3% during the forecast period. Market growth can be largely attributed to factors such as the rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding in major markets, and regulatory approvals and product and service launches. The emerging countries are also expected to offer strong growth opportunities for players in the market. On the other hand, bans on alcohol consumption in Islamic countries and the prohibition of drug testing at workplaces in certain regions are some major factors that may hinder the market growth.

Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=345782

List of Companies Profiled in the Report

  • LabCorp (US)
  • Alere (US)
  • Thermo Fisher (US)
  • Drägerwerk (Germany)
  • Quest Diagnostics (US)
  • Alfa Scientific Designs (US)
  • Lifeloc (US)
  • MPD, Inc. (US)
  • OraSure (US)
  • Omega Laboratories (US)
  • Premier Biotech (US)
  • Psychemedics (US)
  • Roche (Switzerland)
  • Shimadzu (Japan)
  • Seimens Healthineers (US)
  • American Bio Medica Corporation (US)
  • Sciteck, Inc. (US)
  • ACM Global Laboratories (US)
  • CareHealth America (US)
  • Clinical Reference Laboratory (US)

“Drug screening services are expected to grow at the highest CAGR during the forecast period”

Drug screening market is segmented into products and services. The services segment is projected to register the highest CAGR during the forecast period, growth in this segment is attributed to factors such as the growing drug and alcohol consumption worldwide, funding initiatives for drug testing laboratories, new and regular service launches and regulatory approvals, and the geographic expansion of drug and alcohol testing laboratories.

“By sample type, urine samples are expected to dominate the market during the forecast period”

The drug screening market is segmented into urine, breath, hair, oral, and other samples on the basis of sample type. The urine sample segment is expected to dominate the market during the forecast period due to the benefits it offers such as high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results.

“North America will dominate the market during the forecast period.”

Geographically, the drug screening market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2019, North America accounted for the largest share of the drug screening market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the growing consumption of illicit drugs, rising number of drunk-driving cases, growing awareness regarding drug screening tests and the strategic expansion of the market players in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type – Tier 1: 57%, Tier 2: 30%, and Tier 3: 13%
  • By Designation – C-level: 25%, D-level: 44%, and Others: 33%
  • By Region – North America: 40%, Europe: 29%, Asia Pacific: 19%, and Rest of the World: 12%

Research Coverage:

This report provides a detailed picture of the global drug screening market. It aims at estimating the size and future growth potential of the market across different segments, such as product and service, sample type, end user, and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total drug screening market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on drug screening offered by the top 20 players in the drug screening market. The report analyses the drug screening market by product and service, sample type, end user, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various drug screening across key geographic regions.
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the drug screening market.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the drug screening market.

Enquire Here for, Report Enquiry, Discount and Customization @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=345782

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.2 SECONDARY DATA
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.3 PRIMARY DATA
2.3.1 PRIMARY SOURCES
2.3.2 BREAKDOWN OF PRIMARY INTERVIEWS
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
2.4 MARKET ESTIMATION
2.4.1 BOTTOM-UP APPROACH
2.4.2 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION
FIGURE 4 DRUG SCREENING MARKET: TOP-DOWN APPROACH
2.4.3 GROWTH FORECAST
2.5 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION METHODOLOGY
2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY
FIGURE 6 DRUG SCREENING SERVICES MARKET TO RECORD HIGHEST CAGR DURING 2020–2025
FIGURE 7 ANALYTICAL INSTRUMENTS SEGMENT TO LEAD THE DRUG SCREENING PRODUCTS MARKET, 2020–2025 (USD BILLION)
FIGURE 8 WORKPLACES TO SHOW THE HIGHEST GROWTH IN THE END-USER MARKET, 2020–2025 (USD BILLION)
FIGURE 9 GEOGRAPHIC SNAPSHOT OF THE DRUG SCREENING MARKET

4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES IN THE DRUG SCREENING MARKET
FIGURE 10 GROWING CONSUMPTION OF DRUGS AND ALCOHOL TO DRIVE MARKET GROWTH
4.2 DRUG SCREENING MARKET, BY PRODUCT & SERVICE
FIGURE 11 SERVICES SEGMENT TO REGISTER HIGHEST CAGR DURING 2020–2025 (USD BILLION)
4.3 DRUG SCREENING MARKET, BY SAMPLE TYPE
FIGURE 12 ORAL FLUID SAMPLES SEGMENT TO WITNESS HIGHEST CAGR, 2020–2025 (USD BILLION)
4.4 DRUG SCREENING MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 13 INDIA TO WITNESS HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 14 DRUG SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Growing drug and alcohol consumption
5.3.1.2 Enforcement of stringent laws mandating drug and alcohol testing
5.3.1.3 Regulatory approvals and product & service launches
TABLE 1 KEY PRODUCT & SERVICE LAUNCHES (2014–2017)
TABLE 2 RECENT APPROVALS FOR DRUG AND ALCOHOL TESTING PRODUCTS AND SERVICES
5.3.2 RESTRAINTS
5.3.2.1 Ban on alcohol consumption in several Islamic countries
5.3.2.2 Prohibition on workplace drug testing in some countries
5.3.3 OPPORTUNITIES
5.3.3.1 Oral fluid testing
5.3.3.2 Fingerprint-based drug screening
5.3.3.3 Emerging economies
5.3.4 CHALLENGES
5.3.4.1 Accuracy and specificity concerns related to breathalyzers
5.4 VALUE CHAIN ANALYSIS
FIGURE 15 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
5.5 ECOSYSTEM ANALYSIS OF THE DRUG SCREENING PRODUCTS MARKET
FIGURE 16 ECOSYSTEM ANALYSIS
5.6 COVID-19 IMPACT ON THE DRUG SCREENING MARKET

6 DRUG SCREENING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 3 DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)
6.2 DRUG SCREENING SERVICES
6.2.1 GROWING DRUG CONSUMPTION AND STRINGENT LAWS HAVE ENSURED DEMAND SPIKE FOR SERVICES
TABLE 4 DRUG SCREENING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3 DRUG SCREENING PRODUCTS
TABLE 5 DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
6.3.1 ANALYTICAL INSTRUMENTS
TABLE 6 DRUG SCREENING PRODUCTS MARKET FOR ANALYTICAL INSTRUMENTS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 7 DRUG SCREENING PRODUCTS MARKET FOR ANALYTICAL INSTRUMENTS, BY REGION, 2018–2025 (USD MILLION)
6.3.1.1 Breathalyzers
6.3.1.1.1 Law enforcement agencies widely use breathalyzers
TABLE 8 BREATHALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 9 BREATHALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.1.1.2 Fuel-cell breathalyzers
TABLE 10 FUEL-CELL BREATHALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.1.1.3 Semiconductor breathalyzers
TABLE 11 SEMICONDUCTOR BREATHALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.1.1.4 Other breathalyzers
TABLE 12 OTHER BREATHALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.1.2 Immunoassay analyzers
6.3.1.2.1 North America is the largest market for immunoassay analyzers
TABLE 13 IMMUNOASSAY ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.1.3 Chromatography instruments
6.3.1.3.1 Chromatography shows higher accuracy than immunoassays
TABLE 14 CHROMATOGRAPHY INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.2 RAPID TESTING DEVICES
TABLE 15 DRUG SCREENING PRODUCTS MARKET FOR RAPID TESTING DEVICES, BY TYPE, 2018–2025 (USD MILLION)
TABLE 16 DRUG SCREENING PRODUCTS MARKET FOR RAPID TESTING DEVICES, BY REGION, 2018–2025 (USD MILLION)
6.3.2.1 Urine testing devices
6.3.2.1.1 Urine testing provides results within minutes and is used in a wide range of applications
TABLE 17 URINE TESTING DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 18 URINE TESTING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.2.1.2 Drug testing cups
TABLE 19 DRUG TESTING CUPS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.2.1.3 Dip cards
TABLE 20 DIP CARDS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.2.1.4 Drug testing cassettes
TABLE 21 DRUG TESTING CASSETTES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.2.2 Oral fluid testing devices
6.3.2.2.1 Short detection windows, noninvasive nature, and low chance of sample tampering have ensured interest in oral fluid testing
TABLE 22 ORAL FLUID TESTING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.3 CONSUMABLES
TABLE 23 DRUG SCREENING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 24 DRUG SCREENING CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.3.1 Assay kits
6.3.3.1.1 Immunoassay kits provide a rapid, inexpensive method to screen samples
TABLE 25 ASSAY KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.3.2 Sample collection devices
6.3.3.2.1 APAC market for sample collection devices to see high growth
TABLE 26 SAMPLE COLLECTION DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.3.3 Calibrators & controls
6.3.3.3.1 Thermo Fisher Scientific is a prominent manufacturer of calibrators & controls
TABLE 27 CALIBRATORS & CONTROLS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3.3.4 Other consumables
TABLE 28 OTHER CONSUMABLES MARKET, BY REGION, 2018–2025 (USD MILLION)

7 DRUG SCREENING MARKET, BY SAMPLE TYPE
7.1 INTRODUCTION
TABLE 29 DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION)
7.2 URINE SAMPLES
7.2.1 EASE OF COLLECTION AND WELL-DEVELOPED TECHNOLOGY HAVE SUPPORTED THE USE OF URINE SAMPLES
TABLE 30 DRUG SCREENING MARKET FOR URINE SAMPLES, BY REGION, 2018–2025 (USD MILLION)
7.3 BREATH SAMPLES
7.3.1 BREATH ALCOHOL TESTS SEE WIDE USAGE IN WORKPLACE TESTING AND LAW ENFORCEMENT APPLICATIONS
TABLE 31 DRUG SCREENING MARKET FOR BREATH SAMPLES, BY REGION, 2018–2025 (USD MILLION)
7.4 ORAL FLUID SAMPLES
7.4.1 NONINVASIVE SAMPLE COLLECTION AND LOW CHANCE OF ADULTERATION HAVE SUPPORTED RELIANCE ON ORAL SAMPLES
TABLE 32 DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY REGION, 2018–2025 (USD MILLION)
7.5 HAIR SAMPLES
7.5.1 HAIR SAMPLES CAN PROVIDE INSIGHTS INTO LONG-TERM DRUG USE
TABLE 33 DRUG SCREENING MARKET FOR HAIR SAMPLES, BY REGION, 2018–2025 (USD MILLION)
7.6 OTHER SAMPLES
TABLE 34 DRUG SCREENING MARKET FOR OTHER SAMPLES, BY REGION, 2018–2025 (USD MILLION)

8 DRUG SCREENING MARKET, BY END USER

Share This Post